Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancerSara Bobisse, Alexandre Harari|Nature Communications|2018Cited by 166
Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8+ T-cell epitopesDavid Gfeller, Alexandre Harari|Cell Systems|2023Cited by 114
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumorsJulien Schmidt, Alexandre Harari|Nature Communications|2023Cited by 66
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRsRaphaël Genolet, Alexandre Harari|Cell Reports Methods|2023Cited by 48
A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial CarcinomaAlexandre Harari, Lana E. Kandalaft|Cancers|2021Cited by 9